Hikal Limited (BOM:524735)
India · Delayed Price · Currency is INR 222.20
-18.60 (-7.72%)
At close: Sep 4, 2026
Hikal Market Cap
Hikal has a market cap or net worth of 27.4 billion as of September 4, 2026. Its market cap has decreased by -17.09% in one year.
Market Cap
27.40B
Enterprise Value
34.10B
Revenue
17.35B
Ranking
n/a
PE Ratio
n/a
Stock Price
222.20
ChartMarket Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 27.40B, an increase of 1,918.66%. That is a compound annual growth rate of 13.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 27.40B | -2.07% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 44.67B |
| Novartis India | 40.42B |
| Unichem Laboratories | 38.79B |
| Kwality Pharmaceuticals | 34.18B |
| Fredun Pharmaceuticals | 24.38B |
| Shukra Pharmaceuticals | 22.84B |
| Venus Remedies | 22.58B |
| Syncom Formulations (India) | 19.33B |